Unique ID issued by UMIN | UMIN000021121 |
---|---|
Receipt number | R000023996 |
Scientific Title | Open-label multicenter registry on the Outcomes of in-stent restenosis treated by Balloon angioplasty with Optical Frequency Domain Imaging in superficial femoral artery |
Date of disclosure of the study information | 2016/04/01 |
Last modified on | 2019/05/21 08:57:19 |
Open-label multicenter registry on the Outcomes of in-stent restenosis treated by Balloon angioplasty with Optical Frequency Domain Imaging in superficial femoral artery
Open-label multicenter registry on the Outcomes of in-stent restenosis treated by Balloon angioplasty with Optical Frequency Domain Imaging in superficial femoral artery (ISLAND-SFA study)
Open-label multicenter registry on the Outcomes of in-stent restenosis treated by Balloon angioplasty with Optical Frequency Domain Imaging in superficial femoral artery
Open-label multicenter registry on the Outcomes of in-stent restenosis treated by Balloon angioplasty with Optical Frequency Domain Imaging in superficial femoral artery (ISLAND-SFA study)
Japan |
peripheral arterial disease
Cardiology |
Others
NO
The aim of this study is to evaluate restenosis rate at 6 months after balloon angioplasty for patients with in-stent restenosis in superficial femoral artery.And it is to assess lesion by using OFDI before and after balloon angioplasty treatment,
and to evaluate relationship between the OFDI findings and recurrence in-stent restenosis.
Efficacy
Exploratory
Explanatory
Not applicable
Restenosis with duplex ultrasonography at 6 months after balloon angioplasty
1)Rutherford category at 12 months after balloon angioplasty
2)Restenosis with duplex ultrasonography at 12 months after balloon angioplasty
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Device,equipment |
Optical Frequency Domain Imaging
20 | years-old | <= |
Not applicable |
Male and Female
1) patients with in-stent restenosis in superficial femoral artery.
2) peripheral arterial disease (Rutherford 1-5 categories)
3) patients meeting endovascular therapy criteria.
4) patients who can understand this study and provided written informed consent
5) patients aged over 20 years at the time of informed consent
1)patients with in-stent occlusion in superficial femoral artery.
2)patients with all three occlusion artery below the knee
3)patients with uncontrollable heart failure
4)patients with acute limb ischemia or acute thrombotic occlusion
5)patients can not recieve antiplatelet therapy
6)female patients during pregnancy or breast-feeding
7)patients judged inappropriate for this study by physician
60
1st name | |
Middle name | |
Last name | Toshiro Shinke |
Department of Internal Medicine, Kobe University Graduate School of Medicine
Division of Cardiovascular Medicine
7-5-2 Kusunokicho, Chuoku, Kobe-city, Hyogo
078-382-5111
shinke@med.kobe-u.ac.jp
1st name | |
Middle name | |
Last name | Kenichi Yanaka |
Department of Internal Medicine, Kobe University Graduate School of Medicine
Division of Cardiovascular Medicine
7-5-2 Kusunokicho, Chuoku, Kobe-city, Hyogo
078-382-5111
yanadoushies@yahoo.co.jp
Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine
DAIICHI SANKYO COMPANY
Profit organization
NO
2016 | Year | 04 | Month | 01 | Day |
Unpublished
Terminated
2016 | Year | 02 | Month | 10 | Day |
2016 | Year | 03 | Month | 23 | Day |
2016 | Year | 04 | Month | 01 | Day |
2018 | Year | 11 | Month | 01 | Day |
2016 | Year | 02 | Month | 21 | Day |
2019 | Year | 05 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023996